Prediction algorithm for gastric cancer in a general population: A validation study

Worldwide, gastric cancer is a leading cause of cancer incidence and mortality. This study aims to devise and validate a scoring system based on readily available clinical data to predict the risk of gastric cancer in a large Chinese population.

[1]  Wenqiang Wei,et al.  Prediction models for gastric cancer risk in the general population: a systematic review. , 2022, Cancer prevention research.

[2]  Ji Hee Kim,et al.  Association between Statin Use and Gastric Cancer: A Nested Case-Control Study Using a National Health Screening Cohort in Korea , 2021, Pharmaceuticals.

[3]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[4]  V. Wong,et al.  Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong—A Territory-Wide Cohort Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. Wong,et al.  Collateral Effect of Coronavirus Disease 2019 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases: A Territory-wide Observational Study in Hong Kong , 2020, Gastroenterology.

[6]  V. Wong,et al.  Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19 , 2020, Gut.

[7]  S. Tsugane,et al.  Estimation of the performance of a risk prediction model for gastric cancer occurrence in Japan: Evidence from a small external population. , 2020, Cancer epidemiology.

[8]  B. Rapkin,et al.  Utilizing Cultural and Ethnic Variables in Screening Models to Identify Individuals at High Risk for Gastric Cancer: A Pilot Study , 2020, Cancer Prevention Research.

[9]  Lixia Lou,et al.  Sex difference in incidence of gastric cancer: an international comparative study based on the Global Burden of Disease Study 2017 , 2020, BMJ Open.

[10]  T. Naito,et al.  Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: A case-control study , 2019, Scientific Reports.

[11]  Yuan Yuan,et al.  Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study , 2019, Gut.

[12]  W. Leung,et al.  Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence , 2019, Therapeutic advances in gastroenterology.

[13]  T. Ninomiya,et al.  Development and validation of a risk assessment tool for gastric cancer in a general Japanese population , 2018, Gastric Cancer.

[14]  Sin-Ho Jung,et al.  A prediction model for advanced colorectal neoplasia in an asymptomatic screening population , 2017, PloS one.

[15]  S. Ng,et al.  Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. , 2017, Gastroenterology.

[16]  R. Bostick,et al.  A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study , 2017, The American Journal of Gastroenterology.

[17]  A. Hoes,et al.  Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  Fumie 文恵 Ikeda 池田,et al.  Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study , 2016, Journal of epidemiology.

[19]  Jeongseon Kim,et al.  Relationship between Salt Preference and Gastric Cancer Screening: An Analysis of a Nationwide Survey in Korea , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[20]  Byung-Ho Nam,et al.  Prediction Model for Gastric Cancer Incidence in Korean Population , 2015, PloS one.

[21]  I. Choi,et al.  Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort Study , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[22]  J. Sung,et al.  The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects , 2011, Gut.

[23]  Jian-Min Yuan,et al.  Alcohol and Tobacco Use in Relation to Gastric Cancer: A Prospective Study of Men in Shanghai, China , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[24]  Han-Kwang Yang,et al.  Identifying the Risk Factors Through the Development of a Predictive Model for Gastric Cancer in South Korea , 2009, Cancer nursing.

[25]  M. Gail,et al.  Colorectal cancer risk prediction tool for white men and women without known susceptibility. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Jin-Ling Tang,et al.  Health services research in the public healthcare system in Hong Kong: An analysis of over 1 million antihypertensive prescriptions between 2004–2007 as an example of the potential and pitfalls of using routinely collected electronic patient data , 2008, BMC health services research.

[27]  A. Bleyer,et al.  Malignant melanoma in the first three decades of life: A report from the U.S. Surveillance, Epidemiology and End Results (SEER) Program , 2004 .

[28]  Wei Hong Wang,et al.  Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. , 2003, Journal of the National Cancer Institute.

[29]  Ewout W Steyerberg,et al.  Should scoring rules be based on odds ratios or regression coefficients? , 2002, Journal of clinical epidemiology.